130 related articles for article (PubMed ID: 36028966)
41. Flavonols and 4-thioflavonols as potential acetylcholinesterase and butyrylcholinesterase inhibitors: Synthesis, structure-activity relationship and molecular docking studies.
Mughal EU; Sadiq A; Ashraf J; Zafar MN; Sumrra SH; Tariq R; Mumtaz A; Javid A; Khan BA; Ali A; Javed CO
Bioorg Chem; 2019 Oct; 91():103124. PubMed ID: 31319297
[TBL] [Abstract][Full Text] [Related]
42. Characterizations of cholinesterases in golden apple snail (Pomacea canaliculata).
Zou XH; Xie HQ; Zha GC; Chen VP; Sun YJ; Zheng YZ; Tsim KW; Dong TT; Choi RC; Luk WK
J Mol Neurosci; 2014 Jul; 53(3):424-8. PubMed ID: 24217797
[TBL] [Abstract][Full Text] [Related]
43. Plasma B-esterase activities in European raptors.
Roy C; Grolleau G; Chamoulaud S; Rivière JL
J Wildl Dis; 2005 Jan; 41(1):184-208. PubMed ID: 15827224
[TBL] [Abstract][Full Text] [Related]
44. Novel inhibitors with sulfamethazine backbone: synthesis and biological study of multi-target cholinesterases and α-glucosidase inhibitors.
Türkeş C; Akocak S; Işık M; Lolak N; Taslimi P; Durgun M; Gülçin İ; Budak Y; Beydemir Ş
J Biomol Struct Dyn; 2022; 40(19):8752-8764. PubMed ID: 33950796
[TBL] [Abstract][Full Text] [Related]
45. Synthesis and Biological Evaluation of New Cholinesterase Inhibitors for Alzheimer's Disease.
Hussein W; Sağlık BN; Levent S; Korkut B; Ilgın S; Özkay Y; Kaplancıklı ZA
Molecules; 2018 Aug; 23(8):. PubMed ID: 30110946
[TBL] [Abstract][Full Text] [Related]
46. Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer's disease.
Kumar A; Pintus F; Di Petrillo A; Medda R; Caria P; Matos MJ; Viña D; Pieroni E; Delogu F; Era B; Delogu GL; Fais A
Sci Rep; 2018 Mar; 8(1):4424. PubMed ID: 29535344
[TBL] [Abstract][Full Text] [Related]
47. [Design, synthesis and evaluation of tacrine-methoxybenzene hybrids as cholinesterases inhibitors].
Luo W; Zhao YM; Zhang Z; Su YB; Wang CJ
Yao Xue Xue Bao; 2012 Jul; 47(7):916-21. PubMed ID: 22993857
[TBL] [Abstract][Full Text] [Related]
48. [Design, synthesis and cholinesterase inhibitory activity of quinoline-polyamine conjugates].
Luo W; Huang K; Zhang Z; Hong C; Wang CJ
Yao Xue Xue Bao; 2013 Feb; 48(2):269-75. PubMed ID: 23672025
[TBL] [Abstract][Full Text] [Related]
49. Pharmacophore-based drug design of AChE and BChE dual inhibitors as potential anti-Alzheimer's disease agents.
Gao H; Jiang Y; Zhan J; Sun Y
Bioorg Chem; 2021 Sep; 114():105149. PubMed ID: 34252860
[TBL] [Abstract][Full Text] [Related]
50. Synthesis and anticholinesterase activity of new substituted benzo[d]oxazole-based derivatives.
Pouramiri B; Moghimi S; Mahdavi M; Nadri H; Moradi A; Tavakolinejad-Kermani E; Firoozpour L; Asadipour A; Foroumadi A
Chem Biol Drug Des; 2017 May; 89(5):783-789. PubMed ID: 27863021
[TBL] [Abstract][Full Text] [Related]
51. In vitro and in silico analysis of novel astaxanthin-s-allyl cysteine as an inhibitor of butyrylcholinesterase and various globular forms of acetylcholinesterases.
Sakayanathan P; Loganathan C; Kandasamy S; Ramanna RV; Poomani K; Thayumanavan P
Int J Biol Macromol; 2019 Nov; 140():1147-1157. PubMed ID: 31442505
[TBL] [Abstract][Full Text] [Related]
52. Slow-binding inhibition of cholinesterases, pharmacological and toxicological relevance.
Masson P; Lushchekina SV
Arch Biochem Biophys; 2016 Mar; 593():60-8. PubMed ID: 26874196
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of Acetylcholinesterase and Butyrylcholinesterase by a Plant Secondary Metabolite Boldine.
Kostelnik A; Pohanka M
Biomed Res Int; 2018; 2018():9634349. PubMed ID: 29850593
[TBL] [Abstract][Full Text] [Related]
54. Norditerpenoids with Selective Anti-Cholinesterase Activity from the Roots of
Ślusarczyk S; Senol Deniz FS; Abel R; Pecio Ł; Pérez-Sánchez H; Cerón-Carrasco JP; den-Haan H; Banerjee P; Preissner R; Krzyżak E; Oleszek W; E Orhan I; Matkowski A
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32586060
[TBL] [Abstract][Full Text] [Related]
55. Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase.
Pacheco G; Palacios-Esquivel R; Moss DE
J Pharmacol Exp Ther; 1995 Aug; 274(2):767-70. PubMed ID: 7636741
[TBL] [Abstract][Full Text] [Related]
56. Molecular-docking-guided design and synthesis of new IAA-tacrine hybrids as multifunctional AChE/BChE inhibitors.
Cheng ZQ; Zhu KK; Zhang J; Song JL; Muehlmann LA; Jiang CS; Liu CL; Zhang H
Bioorg Chem; 2019 Mar; 83():277-288. PubMed ID: 30391700
[TBL] [Abstract][Full Text] [Related]
57. Discovery of methoxy-naphthyl linked N-(1-benzylpiperidine) benzamide as a blood-brain permeable dual inhibitor of acetylcholinesterase and butyrylcholinesterase.
Abdullaha M; Nuthakki VK; Bharate SB
Eur J Med Chem; 2020 Dec; 207():112761. PubMed ID: 32942070
[TBL] [Abstract][Full Text] [Related]
58. A ratiometric fluorescence probe based on carbon dots for discriminative and highly sensitive detection of acetylcholinesterase and butyrylcholinesterase in human whole blood.
Xu X; Cen Y; Xu G; Wei F; Shi M; Hu Q
Biosens Bioelectron; 2019 Apr; 131():232-236. PubMed ID: 30849722
[TBL] [Abstract][Full Text] [Related]
59. Molecular and Computational Analysis Identify Statins as Selective Inhibitors of Human Butyrylcholinesterase.
Atay MS; Sari S; Bodur E
Protein J; 2023 Apr; 42(2):104-111. PubMed ID: 36648628
[TBL] [Abstract][Full Text] [Related]
60. Quinoxaline derivatives: novel and selective butyrylcholinesterase inhibitors.
Zeb A; Hameed A; Khan L; Khan I; Dalvandi K; Choudhary MI; Basha FZ
Med Chem; 2014; 10(7):724-9. PubMed ID: 24875826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]